Botulinum toxin type A for facial rejuvenation - United States and United Kingdom perspectives

被引:51
作者
Lowe, NJ
机构
[1] Cranley Clin, London W1M 9AD, England
[2] Univ Calif Los Angeles, Sch Med, Dept Dermatol, Los Angeles, CA USA
[3] UCL, Sch Med, Dept Dermatol, London W1N 8AA, England
关键词
D O I
10.1111/j.1524-4725.1998.tb04100.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND. Botulinum A toxin has been well documented as a successful treatment for hyperfunctional upper facial expression lines. Currently, there are two commercial sources for botulinum toxin-Botox(R) and Dysport(R). Only Boton: is currently available in the United States; however, both Botox(R) and Dysport(R) are available in a number of European and other countries. OBJECTIVES. There are several differences between these two sources of botulinum toxin, including different potency of their dosage units. This article will review the uses of these two sources of botulinum toxin and discuss the dilution and dosing of botulinum toxin for facial expression lines. RESULTS. One unit of Botox(R) is approximately equivalent in potency to 4 LT of Dysport(R). CONCLUSIONS. Both commercial types of botulinum toxin can be used interchangeably with appropriate dosage selection. (C) 1998 by the American Society for Dermatologic Surgery, Inc.
引用
收藏
页码:1216 / 1218
页数:3
相关论文
共 15 条
[1]   CONTRALATERAL INJECTIONS OF BOTULINUM-A TOXIN FOR THE TREATMENT OF HEMIFACIAL SPASM TO ACHIEVE INCREASED FACIAL SYMMETRY [J].
BORODIC, GE ;
CHENEY, M ;
MCKENNA, M .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1992, 90 (06) :972-977
[2]   TREATMENT OF GLABELLAR FROWN LINES WITH C-BOTULINUM-A EXOTOXIN [J].
CARRUTHERS, JDA ;
CARRUTHERS, JA .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1992, 18 (01) :17-21
[3]  
DUTTON JJ, 1988, OPHTHALMOLOGY, V95, P1529
[4]   CONTROLLED TRIAL OF BOTULINUM TOXIN INJECTIONS IN THE TREATMENT OF SPASMODIC TORTICOLLIS [J].
GELB, DJ ;
LOWENSTEIN, DH ;
AMINOFF, MJ .
NEUROLOGY, 1989, 39 (01) :80-84
[5]   AESTHETIC INDICATIONS FOR BOTULINUM TOXIN INJECTION [J].
GUYURON, B ;
HUDDLESTON, SW .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1994, 93 (05) :913-918
[6]  
KALRA HK, 1990, OPHTHALMIC SURG LAS, V21, P335
[7]   BOTULINUM TOXIN-A FOR HYPERKINETIC FACIAL LINES - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
KEEN, M ;
BLITZER, A ;
AVIV, J ;
BINDER, W ;
PRYSTOWSKY, J ;
SMITH, H ;
BRIN, M .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1994, 94 (01) :94-99
[8]  
LOWE N, 1995, COSMETIC DERM, V8, P46
[9]   Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection technique [J].
Lowe, NJ ;
Maxwell, A ;
Harper, H .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (04) :569-572
[10]  
SAMPAIO C, 1995, MOVEMENT DISORD, P387